Average Co-Inventor Count = 4.33
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Aegera Therapeutics, Inc. (7 from 24 patents)
2. University of Ottawa (5 from 163 patents)
3. Apoptogen, Inc. (2 from 5 patents)
14 patents:
1. 7776552 - Mammalian IAP gene family, primers, probes and detection methods
2. 7294713 - Antisense IAP oligonucleotides and uses thereof
3. 7087584 - Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
4. 7067281 - Mammalian IAP gene family, primers, probes and detection methods
5. 6977158 - Mammalian IAP gene family, primers, probes, and detection methods
6. 6689562 - Mammalian IAP gene family, primers, probes and detection methods
7. 6673917 - Antisense IAP nucleic acids and uses thereof
8. 6656704 - Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
9. 6541457 - Mammalian IAP gene family, primers, probes and detection methods
10. 6300492 - Modulation of IAPs for the diagnosis and antisense treatment of proliferative disease
11. 6156535 - Mammalian IAP gene family, primers, probes, and detection methods
12. 6133437 - Modulation of IAPs for the treatment of proliferative diseases
13. 6107041 - Detection and modulation of IAPS for the diagnosis and treatment of
14. 5919912 - Mammalian IAP antibodies and diagnostic kits